clinical trial · NCT07160816
A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar
Novo Nordisk A/S·—·active not recruiting·n = 245
Diabetes Mellitus, Type 1Insulin icodec
brief summary
The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.
started
Aug 28, 2025
primary completion
Jan 20, 2027
completion
Jan 20, 2027
last updated
Jun 5, 2026
official title
A Real-world, Multi-centre, Prospective, Non-interventional, Single-arm Study Investigating Glycaemic Control, Treatment Satisfaction and Adherence Associated With the Use of Insulin Icodec in People Living With Type 1 Diabetes
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol